Feature Channels: Vaccines

Filters close
Released: 6-Jan-2023 12:55 PM EST
Vaccine and prior SARS-CoV-2 infection confer long-lasting protection against omicron BA.5
Instituto de Medicina Molecular

A new study led by Luís Graça, group leader at the Instituto de Medicina Molecular João Lobo Antunes (iMM, Lisbon) and full professor at the Medical School of the University of Lisbon, and Manuel Carmo Gomes, associate professor with aggregation at the Faculty of Sciences of the University of Lisbon (Ciências ULisboa), both members of the Direção Geral de Saúde (DGS) Technical Committee for Vaccination against COVID-19 (CTVC), and published today in the scientific journal Lancet Infectious Diseases*, shows that the protection conferred by hybrid immunity against the SARS-CoV-2 subvariant omicron BA.5, obtained by the infection of vaccinated people, lasts for at least eight months after the first infection.

Released: 4-Jan-2023 7:40 PM EST
Does COVID change the body’s response to other threats? Depends on your sex
Yale University

The long-term effects of infection on the immune system have long intrigued John Tsang, a Yale immunobiologist. After the body has faced down a pathogen, does the immune system return to the previous baseline? Or does a single infection change it in ways that alter how it will respond not only to a familiar virus but also to the next new viral or bacterial threat it faces?

Newswise: A Three-Dose Malaria Vaccine Shows Safety, Efficacy in West African Adults
Released: 4-Jan-2023 12:55 PM EST
A Three-Dose Malaria Vaccine Shows Safety, Efficacy in West African Adults
University of Maryland School of Medicine

A three-dose regimen of a whole-parasite vaccine against malaria – called Plasmodium falciparum sporozoite (PfSPZ) vaccine – demonstrated safety and efficacy when tested in adults living in Burkina Faso, West Africa, which has endemic malaria.

Released: 3-Jan-2023 4:10 PM EST
Examination of COVID-19 vaccine reactions after multisystem inflammatory syndrome in children
JAMA - Journal of the American Medical Association

In this study of study of 385 patients ages 5 or older with a history of multisystem inflammatory syndrome in children (MIS-C), no serious adverse events were reported after COVID-19 vaccination.

Newswise: December Research Highlights
Released: 29-Dec-2022 5:45 PM EST
December Research Highlights
Cedars-Sinai

A roundup of the latest medical discoveries and faculty news at Cedars-Sinai.

Newswise: UT Southwestern rheumatologist recommends patients receive pneumococcal vaccine
Released: 28-Dec-2022 11:30 AM EST
UT Southwestern rheumatologist recommends patients receive pneumococcal vaccine
UT Southwestern Medical Center

Patients with rheumatoid arthritis, lupus, and other rheumatic conditions are more at risk for complications and death from pneumonia, meningitis, and other bacterial infections, yet most have not been vaccinated against infection.

Newswise: COVID-19 booster increases durability  of antibody response, research shows
Released: 22-Dec-2022 2:40 PM EST
COVID-19 booster increases durability of antibody response, research shows
University of Virginia Health System

New research from the University of Virginia School of Medicine speaks to the benefits of a COVID-19 booster.

Released: 21-Dec-2022 10:05 AM EST
Especialista da Mayo Clinic explica por que é importante que as crianças sejam vacinadas contra o HPV
Mayo Clinic

Há mais de 100 variedades de papilomavírus humano (HPV), uma infecção viral que, normalmente causa verrugas. Porém, alguns tipos de HPV podem causar câncer no colo do útero, ânus, pênis, vagina, vulva e garganta.

Released: 21-Dec-2022 10:05 AM EST
Experta de Mayo Clinic explica la importancia de que los niños reciban la vacuna contra el virus del papiloma humano (VPH)
Mayo Clinic

Existen más de 100 variedades del virus del papiloma humano (HPV), que es una infección viral que normalmente causa verrugas. Sin embargo, algunos tipos de VPH pueden causar cáncer de cuello uterino, ano, pene, vagina, vulva y garganta.

Released: 21-Dec-2022 9:55 AM EST
Tis the season to manage stress: Winter holiday story ideas and expert commentary
Newswise

Here are some of the latest articles that have been added to the Winter Holidays channel on Newswise.

   
Released: 21-Dec-2022 9:00 AM EST
A Deepening Partnership: How CHLA and Macedonia Baptist Church Are Tackling Health Inequities in South L.A.
Children's Hospital Los Angeles

“A ZIP code should not determine the life expectancy nor the diseases that we get,” says Alejandro “Alex” Guerrero, Executive Director of the Macedonia Community Development Corporation.

Newswise: RUDN University virologists evaluated the effectiveness of hepatitis A vaccination
Released: 21-Dec-2022 6:05 AM EST
RUDN University virologists evaluated the effectiveness of hepatitis A vaccination
Scientific Project Lomonosov

RUDN University virologists measured the level of herd immunity to hepatitis A virus in different regions of Russia. The results make it possible to assess the effectiveness of the vaccination program. The study showed that mass vaccination should be introduced in all regions

Released: 21-Dec-2022 12:05 AM EST
خبير من مايو كلينك يشرح أهمية حصول الأطفال على لقاح فيروس الورم الحليمي البشري
Mayo Clinic

هناك أكثر من 100 نوع من فيروس الورم الحليمي البشري (HPV)، وهو عدوى فيروسية شائعة عادة ما تسبب البثور، إلا إن بعض أنواع فيروس الورم الحليمي البشري قد تسبب سرطانات في عنق الرحم، والشرج، والقضيب، والمهبل، والفرج، والحلق.

Released: 20-Dec-2022 7:55 PM EST
Chinese Communist Party zero-covid “volunteers” have suffered from stress and anxiety, study shows
University of Exeter

“Volunteers” tasked with enforcing the Chinese Communist Party’s zero-covid policies have suffered from stress and anxiety, a new study shows.

Released: 20-Dec-2022 6:55 PM EST
First-line immune defences against COVID-19 are short-lived and may explain reinfection
Imperial College London

A new study finds that antibodies produced in the nose decline nine months after COVID-19 infection, while antibodies found in the blood last at least a year.

Released: 20-Dec-2022 11:05 AM EST
What You Should Know About Mpox
Children's Hospital Los Angeles

Find out what special pathogens expert Erika Cheung, MSN, RN, CPN, has to say about the disease, which the WHO has declared a public health emergency of international concern. Since May 18, 2022, cases of mpox have been spreading in the United States, including California. On July 23, 2022, the World Health Organization (WHO) declared the current outbreak a public health emergency of international concern.

Released: 19-Dec-2022 3:35 PM EST
Texas Biomed at forefront of Sudan ebolavirus biomedical R&D
Texas Biomedical Research Institute

A Sudan ebolavirus vaccine and antibody therapeutic tested at Texas Biomedical Research Institute have been sent to Uganda as part of efforts to control the outbreak there.

Released: 19-Dec-2022 1:45 PM EST
Why do many young cancer survivors forgo human papillomavirus vaccination?
Wiley

Study uncovers certain vaccine-related concerns that should be addressed by health care providers.

Released: 16-Dec-2022 12:00 PM EST
Inoculation from the vaccine does not transfer over to blood transfusion patient
Newswise

The claim that a blood transfusion could pass on the inoculation from a vaccine is entirely false.

Released: 16-Dec-2022 9:50 AM EST
Large, real-world study finds COVID-19 vaccination more effective than natural immunity in protecting against all causes of death, hospitalization and emergency department visits
Regenstrief Institute

In one of the first large, real-world studies comparing the effectiveness of COVID-19 vaccines versus natural immunity in protecting against death, hospitalizations and emergency department (ED) visits for any cause, including COVID, research-scientists from Regenstrief Institute, Indiana University School of Medicine and Vanderbilt University Medical Center report that people of all age groups benefited significantly more from vaccination than natural immunity acquired from a previous COVID infection.

Released: 16-Dec-2022 9:25 AM EST
New DNA Analysis Provides First Accurate Tuberculosis Genome
Rutgers University-New Brunswick

Rutgers researchers hope their genome-assembly tool will spur the development of new treatments for bacterial infections.

Released: 15-Dec-2022 12:05 PM EST
Hackensack Meridian School of Medicine’s COVID Support Our Schools Initiative Assisting at Peak of Pandemic Publishes Findings
Hackensack Meridian Health

The paper concludes the COVID Support Our Schools (SOS) program helped underserved communities at a critical time - and its benefits could help with community health outreach beyond the time of a pandemic

Newswise: Shift workers have a higher risk of severe COVID-19
Released: 13-Dec-2022 2:55 PM EST
Shift workers have a higher risk of severe COVID-19
University of Bergen

Working night shifts is associated with several negative health outcomes, including an increased risk of infections.

Newswise: Attitudes around COVID-19 vaccination are linked to increased traffic risks
Released: 12-Dec-2022 6:45 PM EST
Attitudes around COVID-19 vaccination are linked to increased traffic risks
Elsevier

Reasons underlying hesitancy to get vaccinated against COVID-19 may be associated with increased risks of traffic accidents according to a new study in The American Journal of Medicine, published by Elsevier.

6-Dec-2022 2:00 PM EST
Early engagement with affected communities helped to control mpox outbreak in Montreal
American College of Physicians (ACP)

An analysis of the first large mpox outbreak in North America found that early, sustained engagement and rapid offering of preexposure vaccination to affected communities successfully controlled the spread of the outbreak. The analysis is published in Annals of Internal Medicine.

Released: 12-Dec-2022 2:30 PM EST
Antibody discovery paves way for new therapies against group A streptococcal infections
Lund University

Researchers at Lund University in Sweden have discovered an antibody with the potential to protect against Strep A infection, as well as a rare form of antibody binding, that leads to an effective immune response against bacteria.

Newswise: COVID Infection, Vaccination Linked to Heart Condition
Released: 12-Dec-2022 1:25 PM EST
COVID Infection, Vaccination Linked to Heart Condition
Cedars-Sinai

Investigators from the Smidt Heart Institute at Cedars-Sinai validated the link between a debilitating heart condition and COVID-19 and, to a lesser extent, a novel link between the same condition and COVID-19 vaccination.

Released: 12-Dec-2022 9:40 AM EST
Studies find Omicron related hospitalisations lower in severity than Delta and Pfizer-BioNTech COVID vaccine remains effective in preventing hospitalisations
University of Bristol

Adult hospitalisations from Omicron-related SARS-CoV-2 (COVID-19) were less severe than Delta and the Pfizer-BioNTech vaccine remains effective in preventing not only hospitalisation, but severe patient outcomes associated with COVID-19, two new research studies have found.

Newswise: Polarization after COVID-19: Global study published in Nature reveals that the unvaccinated face prejudice in most countries
Released: 8-Dec-2022 7:00 PM EST
Polarization after COVID-19: Global study published in Nature reveals that the unvaccinated face prejudice in most countries
Aarhus University

Across all inhabited continents of the world, people show prejudice and discriminatory attitudes towards individuals not vaccinated against COVID-19.

Released: 8-Dec-2022 1:55 PM EST
New STAT1-us quo? Novel STAT1 variants cause MSMD
Tokyo Medical and Dental University

Usually, the scariest part of childhood vaccination, for both kids and parents, is the needles. In rare cases, however, vaccines can have unexpectedly negative effects, and the secret lies in our genes.

Released: 8-Dec-2022 12:20 PM EST
Two UCI researchers named fellows by the National Academy of Inventors
University of California, Irvine

Irvine, Calif., Dec. 8, 2022 — The National Academy of Inventors has named two University of California, Irvine researchers as fellows for 2022. Philip Felgner, a pioneer in the development of lifesaving mRNA vaccines, and Payam Heydari, a prolific creator of cutting-edge microelectronics technologies, were both recognized for inventions that have made tangible impact on quality of life, economic development and the welfare of society.

Newswise: Phase 1 Trial of the First-In Human HIV Vaccine Shows Promising Results
Released: 8-Dec-2022 10:05 AM EST
Phase 1 Trial of the First-In Human HIV Vaccine Shows Promising Results
George Washington University

The George Washington University Vaccine Research Unit in partnership with Scripps Research, IAVI, Fred Hutchinson Cancer Center (FHCC) and the National Institutes of Health, National Institute of Allergy and Infectious Diseases Vaccine Research Center published the results of their Phase 1 Clinical Trial in Science.

Released: 7-Dec-2022 4:55 PM EST
妙佑医疗国际(Mayo Clinic)专家谈儿童接种HPV疫苗的重要性
Mayo Clinic

人乳头状瘤病毒(HPV)具有100多种变异株,感染这种病毒通常会引发疣。HPV的某些变异株还可导致宫颈癌、肛门癌、阴茎癌、阴道癌、外阴癌以及咽喉癌。

7-Dec-2022 8:05 AM EST
New Receptor “Decoy” Drug Neutralizes COVID-19 Virus and Its Variants
Dana-Farber Cancer Institute

Scientists at Dana-Farber Cancer Institute have developed a drug that potently neutralizes SARS-CoV-2, the COVID-19 coronavirus, and is equally effective against the Omicron variant and every other tested variant. The drug is designed in such a way that natural selection to maintain infectiousness of the virus should also maintain the drug’s activity against future variants.

Released: 7-Dec-2022 11:35 AM EST
National study confirms breakthrough COVID cases are less severe than COVID in unvaccinated adults
Regenstrief Institute

Individuals who, despite having been vaccinated against COVID-19, develop the disease and are hospitalized are less likely to go to an intensive care unit (ICU), more likely to have a shorter hospital stay, and less likely to die in the hospital than individuals hospitalized for COVID who were never vaccinated, according to a national study from the Centers for Disease Control and Prevention’s VISION Network.

Newswise:Video Embedded lji-scientists-confirm-smallpox-vaccine-also-teaches-t-cells-to-fight-mpox
VIDEO
Released: 6-Dec-2022 8:30 PM EST
LJI scientists confirm smallpox vaccine also teaches T cells to fight mpox
La Jolla Institute for Immunology

"Vaccines such as JYNNEOS should be able to induce T cells that also recognize mpox and can provide protection from severe disease."

   
Released: 5-Dec-2022 4:05 PM EST
We ain't misbehavin' here. The latest news in Behavioral Science on Newswise
Newswise

Here are some of the latest articles that have been added to the Behavioral Science channel on Newswise, a free source for journalists.

       
Released: 5-Dec-2022 11:10 AM EST
Dramatic change in proportion of the Canadian population with SARS-CoV-2 antibody over the first 2.5 years of pandemic
Canadian Medical Association Journal

By August 2022, most children and adults younger than 60 years in Canada had been exposed to SARS-CoV-2 through a combination of vaccination and infection, according to a large study looking at blood antibodies published in CMAJ (Canadian Medical Association Journal)

2-Dec-2022 5:50 PM EST
Vaccine hesitancy predicts future COVID-19 vaccine side effects
Bar-Ilan University

The precise relationship between vaccine hesitancy and COVID-19 vaccination side effects has not previously been explored in vaccinated persons. A fundamental question arises in regard to the directionality of this vaccine hesitancy-vaccine side effect link, namely which variable predicts which. One possibility is that side effects from an earlier dose predict one’s vaccine hesitancy towards a later dose. Alternatively, one’s psychological negativity (hesitancy) towards an earlier dose could predict subsequent side effects from a later vaccination dose. The latter direction reflects a Nocebo effect, i.e., side effects driven by psychological factors rather than by an active treatment component. Results showed only the latter direction to be true. Namely, only earlier vaccine hesitancy towards the second COVID-19 dose predicted subsequent nocebo side-effects following the booster vaccination. To put this in perspective up to 16% of one’s vaccine side effects were explained by earlier va

Released: 1-Dec-2022 7:55 PM EST
Immune T cell defence is coping with COVID-19 variants of concern – for now
University of Birmingham

Immune T cells are continuing to target the spike protein of SARS-CoV-2 variants of concern, although mutations are making some T cells less effective, according to new research.

Released: 1-Dec-2022 4:55 PM EST
Icahn School of Medicine at Mount Sinai Continues Drive to Diversify Research by Appointing New Biomedical Laureates
Mount Sinai Health System

The Icahn School of Medicine at Mount Sinai announced today the appointment of two new Laureates as part of its Biomedical Laureates Program, bringing the total to five appointments for this year and furthering its institutional commitment to broadening faculty diversity and mentorship opportunities.

Newswise: Experimental COVID-19 Vaccine Offers Long-term Protection Against Severe Disease
Released: 1-Dec-2022 2:30 PM EST
Experimental COVID-19 Vaccine Offers Long-term Protection Against Severe Disease
University of North Carolina School of Medicine

SARS-CoV-2 vaccines protected infant rhesus macaques against 1 severe lung disease after high dose challenge one year after vaccination.

Newswise: Flu shots are recommended for those 65 and older as cases rise
Released: 1-Dec-2022 9:05 AM EST
Flu shots are recommended for those 65 and older as cases rise
UT Southwestern Medical Center

With flu cases on the rise, geriatric specialists at UT Southwestern Medical Center say vaccinations are particularly important this year for people 65 and older who are more at risk from complications than other age groups.

Released: 30-Nov-2022 12:40 PM EST
Clover’s vaccine candidate reduced household transmission of SARS-CoV-2 in study
International Vaccine Institute

The study, a collaboration between Clover and the International Vaccine Institute, showed that a household contact was 84% less likely to get a SARS-CoV-2 infection when the infected household member had received SCB-2019 (CpG 1018/Alum) compared to placebo

Newswise: COVID-19 vaccine’s effectiveness diminishes with age, research shows
Released: 29-Nov-2022 4:00 PM EST
COVID-19 vaccine’s effectiveness diminishes with age, research shows
UT Southwestern Medical Center

The Pfizer-BioNTech COVID-19 vaccine limits transmission, hospitalization, and death from COVID-19 even among patients infected by variants of the virus, but the effectiveness of antibodies it generates diminishes as patients get older, according to a study by UT Southwestern researchers.

Released: 29-Nov-2022 1:10 PM EST
Young people make up greater proportion of COVID-19 deaths in 2021 compared to 2020
Brigham and Women’s Hospital

Since March 2020, COVID-19-related deaths claimed over a million lives in the U.S. alone.

Released: 29-Nov-2022 8:05 AM EST
Jurata Thin Film Raises $5 Million Seed Round
Jurata Thin Film

Jurata Thin Film, a startup focused on stabilizing vaccines at ambient temperature has raised initial investment funds totaling $4.87 million to develop the technology.



close
2.75423